CPHD Share Price

Open 52.95 Change Price %
High 53.00 1 Day 0.00 0.00
Low 52.95 1 Week 0.00 0.00
Close 52.95 1 Month 0.00 0.00
Volume 2651121 1 Year 17.38 48.86
52 Week High 53.91
52 Week Low 34.00
CPHD Important Levels
Resistance 2 53.00
Resistance 1 52.98
Pivot 52.97
Support 1 52.92
Support 2 52.90
NASDAQ USA Most Active Stocks
DCTH 0.15 -11.76%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
QQQ 141.23 -0.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.03 50.00%
LOCM 0.09 50.00%
FALC 0.25 38.89%
VRTA 4.50 38.46%
ESMC 0.13 30.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
STXS 0.68 25.93%
OTT 2.39 25.13%
ATRM 1.70 21.43%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
PTSX 0.05 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

CEPHEID (NASDAQ: CPHD)

CPHD Technical Analysis 5
As on 4th Nov 2016 CPHD Share Price closed @ 52.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 35.92 & Strong Buy for SHORT-TERM with Stoploss of 49.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
CPHD Target for August
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
CPHD Other Details
Segment EQ
Market Capital 2057364736.00
Sector Technology
Industry Scientific & Technical Instruments
Offical website http://www.cepheid.com
CPHD Address
CPHD
904 Caribbean Drive
Sunnyvale, CA 94089
United States
Phone: 408-541-4191
Fax: 408-541-4192
CPHD Latest News
Interactive Technical Analysis Chart CEPHEID ( CPHD NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on CEPHEID
CPHD Business Profile
Cepheid is a molecular diagnostics company that develops, manufactures and markets fully-integrated systems for testing in the Clinical market, as well as for application in its legacy Non-Clinical market. The Company�s systems enable rapid, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company�s two principal systems are the GeneXpert and SmartCycler. The GeneXpert system, its primary offering in the Clinical market, integrates sample preparation in addition to DNA amplification and detection. The GeneXpert system is designed for a broad range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors� offices. The SmartCycler system integrates DNA amplification and detection to allow rapid analysis of a sample.